Clinical features | Ν (%) | Both Variant A & E | Rest | Pearson χ 2 or Fisher’s exact | N (%) | Either Variant A OR E | No variant | Pearson χ 2 or Fisher’s exact |
---|---|---|---|---|---|---|---|---|
n (%) | n (%) | p-value | n (%) | n (%) | p-value | |||
Age Group | 0.036 | 0.535 | ||||||
< =50 years | 26 (35.6) | 3 (15.8) | 23 (42.6) | 26 (35.6) | 17 (33.3) | 9 (40.9) | ||
> 50 years | 47 (64.4) | 16 (84.2) | 31 (57.4) | 47 (64.4) | 34 (66.7) | 13 (59.1) | ||
Tumor Size | 0.778 | 0.778 | ||||||
≤ 2.0 cm | 59 (67.0) | 18 (69.2) | 41 (66.1) | 59 (67.0) | 41 (66.1) | 18 (69.2) | ||
> 2.0 cm | 29 (33.0) | 8 (30.8) | 21 (33.9) | 29 (33.0) | 21 (33.9) | 8 (30.8) | ||
Histopathological Type | 0.733 | 0.642 | ||||||
Lobular & rest | 18 (20.0) | 5 (17.9) | 13 (21.0) | 18 (20.0) | 12 (18.8) | 6 (23.1) | ||
Intraductal infiltrating | 72 (80.0) | 23 (82.1) | 49 (79.0) | 72 (80.0) | 52 (81.3) | 20 (76.9) | ||
Lymph-node Involvement | 0.571 | 0.072 | ||||||
Negative (Ν0) | 55 (67.1) | 15 (62.5) | 40 (69.0) | 55 (67.1) | 34 (60.7) | 21 (80.8) | ||
Positive (Ν+) | 27 (32.9) | 9 (37.5) | 18 (31.0) | 27 (32.9) | 22 (39.3) | 5 (19.2) | ||
Metastasis | 0.098 | 0.043 | ||||||
Negative M0 | 47 (85.5) | 13 (72.2) | 34 (91.9) | 47 (85.5) | 29 (78.4) | 18 (100.0) | ||
Positive M1 | 8 (14.5) | 5 (27.8) | 3 (8.1) | 8 (14.5) | 8 (21.6) | 0 (0.0) | ||
Grade | 0.215 | 0.810 | ||||||
Low (1–2) | 60 (73.2) | 16 (64.0) | 44 (77.2) | 60 (73.2) | 42 (72.4) | 18 (75.0) | ||
High (3) | 22 (26.8) | 9 (36.0) | 13 (22.8) | 22 (26.8) | 16 (27.6) | 6 (25.0) | ||
Estrogen-receptor Status | 0.166 | 0.509 | ||||||
Negative | 21 (23.9) | 9 (33.3) | 12 (19.7) | 21 (23.9) | 16 (25.8) | 5 (19.2) | ||
Positive | 67 (76.1) | 18 (66.7) | 49 (80.3) | 67 (76.1) | 46 (74.2) | 21 (80.8) | ||
Progesterone-receptor Status | 0.383 | 0.457 | ||||||
Negative | 46 (52.3) | 16 (59.3) | 30 (49.2) | 46 (52.3) | 34 (54.8) | 12 (46.2) | ||
Positive | 42 (47.7) | 11 (40.7) | 31 (50.8) | 42 (47.7) | 28 (45.2) | 14 (53.8) | ||
HER2 Overexpression Status | 0.546 | 0.375 | ||||||
Negative | 72 (81.8) | 20 (76.9) | 52 (83.9) | 72 (81.8) | 49 (79.0) | 23 (88.5) | ||
Positive | 16 (18.2) | 6 (23.1) | 10 (16.1) | 16 (18.2) | 13 (21.0) | 3 (11.5) | ||
TNBC, n (%) | 0.646 | 0.563 | ||||||
Yes | 17 (19.3) | 6 (22.2) | 11 (18.0) | 17 (19.3) | 11 (17.7) | 6 (23.1) | ||
No | 71 (80.7) | 21 (77.8) | 50 (82.0) | 71 (80.7) | 51 (82.3) | 20 (76.9) |